Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |